Main Street Capital Reports Preliminary Q2 Net Investment Income Expectation-March 2024-www.financetom.com

Publish for free

financetom

Business

/

Business

/

Main Street Capital Reports Preliminary Q2 Net Investment Income Expectation

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Main Street Capital Reports Preliminary Q2 Net Investment Income Expectation

Jul 16, 2024 5:19 AM

07:48 AM EDT, 07/16/2024 (MT Newswires) -- Main Street Capital ( MAIN ) reported expected Q2 preliminary net investment income Tuesday of $1 to $1.02 per share.

Analysts polled by Capital IQ expect $1.01.

Price: 51.96, Change: +0.29, Percent Change: +0.56

Previous page： Buckle Insider Sold Shares Worth $854,496, According to a Recent SEC Filing Next page： Update: Moderna Shares Fall After Cutting Annual R&D Spending by $1.1 Billion From 2027

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Sign up to post

Show More Comments

Related Articles >

Buckle Insider Sold Shares Worth $854,496, According to a Recent SEC Filing

Buckle Insider Sold Shares Worth $854,496, According to a Recent SEC Filing

11:08 AM EDT, 09/12/2024 (MT Newswires) -- Dennis H Nelson, Director, President & CEO, on September 10, 2024, sold 20,453 shares in Buckle (BKE) for $854,496. Following the Form 4 filing with the SEC, Nelson has control over a total of 2,310,552 shares of the company, with 324,000 shares held directly and 1,986,552 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/885245/000088524524000087/xslF345X05/wk-form4_1726153070.xml Price: 41.56,...

Update: Moderna Shares Fall After Cutting Annual R&D Spending by $1.1 Billion From 2027

Update: Moderna Shares Fall After Cutting Annual R&D Spending by $1.1 Billion From 2027

11:09 AM EDT, 09/12/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.) Moderna ( MRNA ) shares fell more than 18% in recent Thursday trading after the company said it is reducing its annual R&D expense by about $1.1 billion starting in 2027 in light of recent commercial challenges. The company now...

--Street Color: US FDA Authorizes Over-the-Counter Hearing Aid Software for Apple's AirPods Pro

--Street Color: US FDA Authorizes Over-the-Counter Hearing Aid Software for Apple's AirPods Pro

11:09 AM EDT, 09/12/2024 (MT Newswires) -- Price: 222.76, Change: +0.10, Percent Change: +0.04 ...

Oncternal Therapeutics Ends Clinical Studies, Explores Strategic Options; Shares Fall

Oncternal Therapeutics Ends Clinical Studies, Explores Strategic Options; Shares Fall

11:13 AM EDT, 09/12/2024 (MT Newswires) -- Oncternal Therapeutics' ( ONCT ) shares sank 58% in recent Thursday trading after the company said it has decided to discontinue its clinical studies and explore strategic alternatives. The company also said it will discontinue all product development activities, lay off some staff, and implement other cost-cutting measures while exploring alternatives, which may...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP

Copyright 2023-2026 - www.financetom.com All Rights Reserved